Drug comparisons
Vildagliptin vs Lixisenatide
Vildagliptin vs Lixisenatide: Oral DPP-4 vs injectable GLP-1 for T2DM. Weigh A1C control, GI side effects, weight loss, and injection vs pill convenience.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when selecting between an oral DPP-4 inhibitor and an injectable GLP-1 agonist for type 2 diabetes patients needing better glycemic control or weight management.
Bottom line
Lixisenatide typically offers stronger A1C reduction and weight loss while Vildagliptin provides oral convenience with a milder GI side-effect profile.
All medication comparisons